Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass

N. C. Cavarocchi, Hartzell V Schaff, T. A. Orszulak, H. A. Homburger, W. A. Schnell, J. R. Pluth

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Complement activation by alternate pathway has been implicated in the pathophysiology of cardiopulmonary bypass (CPB), and laboratory studies suggest that the complement cascade may be activated by the protamine-heparin complex. To determine if the administration of protamine to patients receiving heparin activates complement, we studied 100 patients undergoing CPB by assaying levels of C3a and C4a (classic pathway) at regular intervals before and after protamine administration. In group I (90 patients), protamine was given at the usual interval (median 5 minutes) after CPB. In group II (10 patients), protamine was withheld until skin closure (median 45 minutes) after CPB. Results demonstrated that C4a was not activated during CPB in either group. After CPB, the C4a level in group I was 459 ng/dl and increased to 1047 ng/dl 10 minutes after protamine administration (p<0.001). In group II, the C4a level was 484 ng/dl at the end of CPB and 354 ng/dl 15 minutes later, which corresponds to the value immediately after protamine administration in group I. The delayed administration of protamine in group II caused a significant increase in C4a at the time of skin closure (1090 ng/dl; p<0.001). Corresponding results from C3a analysis before and after protamine administration confirmed the activation of complement cascade. Our study provides the first clinical evidence that the protamine-heparin complex activates complement via the classic ((C4a) pathway. The hemodynamic effects of protamine after CPB may be related to complement activation.

Original languageEnglish (US)
Pages (from-to)525-531
Number of pages7
JournalSurgery
Volume98
Issue number3
StatePublished - 1985

Fingerprint

Protamines
Complement Activation
Cardiopulmonary Bypass
Heparin
Skin
Hemodynamics

ASJC Scopus subject areas

  • Surgery

Cite this

Cavarocchi, N. C., Schaff, H. V., Orszulak, T. A., Homburger, H. A., Schnell, W. A., & Pluth, J. R. (1985). Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery, 98(3), 525-531.

Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. / Cavarocchi, N. C.; Schaff, Hartzell V; Orszulak, T. A.; Homburger, H. A.; Schnell, W. A.; Pluth, J. R.

In: Surgery, Vol. 98, No. 3, 1985, p. 525-531.

Research output: Contribution to journalArticle

Cavarocchi, NC, Schaff, HV, Orszulak, TA, Homburger, HA, Schnell, WA & Pluth, JR 1985, 'Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass', Surgery, vol. 98, no. 3, pp. 525-531.
Cavarocchi NC, Schaff HV, Orszulak TA, Homburger HA, Schnell WA, Pluth JR. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery. 1985;98(3):525-531.
Cavarocchi, N. C. ; Schaff, Hartzell V ; Orszulak, T. A. ; Homburger, H. A. ; Schnell, W. A. ; Pluth, J. R. / Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. In: Surgery. 1985 ; Vol. 98, No. 3. pp. 525-531.
@article{3e0fede88e7b41109944d6059ff0ca91,
title = "Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass",
abstract = "Complement activation by alternate pathway has been implicated in the pathophysiology of cardiopulmonary bypass (CPB), and laboratory studies suggest that the complement cascade may be activated by the protamine-heparin complex. To determine if the administration of protamine to patients receiving heparin activates complement, we studied 100 patients undergoing CPB by assaying levels of C3a and C4a (classic pathway) at regular intervals before and after protamine administration. In group I (90 patients), protamine was given at the usual interval (median 5 minutes) after CPB. In group II (10 patients), protamine was withheld until skin closure (median 45 minutes) after CPB. Results demonstrated that C4a was not activated during CPB in either group. After CPB, the C4a level in group I was 459 ng/dl and increased to 1047 ng/dl 10 minutes after protamine administration (p<0.001). In group II, the C4a level was 484 ng/dl at the end of CPB and 354 ng/dl 15 minutes later, which corresponds to the value immediately after protamine administration in group I. The delayed administration of protamine in group II caused a significant increase in C4a at the time of skin closure (1090 ng/dl; p<0.001). Corresponding results from C3a analysis before and after protamine administration confirmed the activation of complement cascade. Our study provides the first clinical evidence that the protamine-heparin complex activates complement via the classic ((C4a) pathway. The hemodynamic effects of protamine after CPB may be related to complement activation.",
author = "Cavarocchi, {N. C.} and Schaff, {Hartzell V} and Orszulak, {T. A.} and Homburger, {H. A.} and Schnell, {W. A.} and Pluth, {J. R.}",
year = "1985",
language = "English (US)",
volume = "98",
pages = "525--531",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass

AU - Cavarocchi, N. C.

AU - Schaff, Hartzell V

AU - Orszulak, T. A.

AU - Homburger, H. A.

AU - Schnell, W. A.

AU - Pluth, J. R.

PY - 1985

Y1 - 1985

N2 - Complement activation by alternate pathway has been implicated in the pathophysiology of cardiopulmonary bypass (CPB), and laboratory studies suggest that the complement cascade may be activated by the protamine-heparin complex. To determine if the administration of protamine to patients receiving heparin activates complement, we studied 100 patients undergoing CPB by assaying levels of C3a and C4a (classic pathway) at regular intervals before and after protamine administration. In group I (90 patients), protamine was given at the usual interval (median 5 minutes) after CPB. In group II (10 patients), protamine was withheld until skin closure (median 45 minutes) after CPB. Results demonstrated that C4a was not activated during CPB in either group. After CPB, the C4a level in group I was 459 ng/dl and increased to 1047 ng/dl 10 minutes after protamine administration (p<0.001). In group II, the C4a level was 484 ng/dl at the end of CPB and 354 ng/dl 15 minutes later, which corresponds to the value immediately after protamine administration in group I. The delayed administration of protamine in group II caused a significant increase in C4a at the time of skin closure (1090 ng/dl; p<0.001). Corresponding results from C3a analysis before and after protamine administration confirmed the activation of complement cascade. Our study provides the first clinical evidence that the protamine-heparin complex activates complement via the classic ((C4a) pathway. The hemodynamic effects of protamine after CPB may be related to complement activation.

AB - Complement activation by alternate pathway has been implicated in the pathophysiology of cardiopulmonary bypass (CPB), and laboratory studies suggest that the complement cascade may be activated by the protamine-heparin complex. To determine if the administration of protamine to patients receiving heparin activates complement, we studied 100 patients undergoing CPB by assaying levels of C3a and C4a (classic pathway) at regular intervals before and after protamine administration. In group I (90 patients), protamine was given at the usual interval (median 5 minutes) after CPB. In group II (10 patients), protamine was withheld until skin closure (median 45 minutes) after CPB. Results demonstrated that C4a was not activated during CPB in either group. After CPB, the C4a level in group I was 459 ng/dl and increased to 1047 ng/dl 10 minutes after protamine administration (p<0.001). In group II, the C4a level was 484 ng/dl at the end of CPB and 354 ng/dl 15 minutes later, which corresponds to the value immediately after protamine administration in group I. The delayed administration of protamine in group II caused a significant increase in C4a at the time of skin closure (1090 ng/dl; p<0.001). Corresponding results from C3a analysis before and after protamine administration confirmed the activation of complement cascade. Our study provides the first clinical evidence that the protamine-heparin complex activates complement via the classic ((C4a) pathway. The hemodynamic effects of protamine after CPB may be related to complement activation.

UR - http://www.scopus.com/inward/record.url?scp=0022339265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022339265&partnerID=8YFLogxK

M3 - Article

C2 - 3875906

AN - SCOPUS:0022339265

VL - 98

SP - 525

EP - 531

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 3

ER -